Profile Picture
  • All
  • Search
  • Images
  • Videos
  • Maps
  • News
  • Copilot
  • More
    • Shopping
    • Flights
    • Travel
  • Notebook
  • Top stories
  • Winter Games
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
Order byBest matchMost fresh
  • Past 24 hours
    • Any time
    • Past hour
    • Past 7 days
    • Past 30 days
Pharmabiz
19h

US FDA accepts Affinia Therapeutics’ IND application of AFTX-201 for phase 1/2 clinical trial to treat BAG3 DCM

Waltham, Massachusetts Saturday, February 7, 2026, 18:00 Hrs [IST] ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

Trending now

Releases new video
Sentenced to 40 years
FDA issues recall
Blackburn seeks Jackson probe
Wins first gold medal
Television bassist dies
3 Doors Down singer dies
Eddie Lacy sentenced
Hochul signs medical aid act
Pentagon to cut academic ties
Sending $6M in aid to Cuba
AZ abortion laws blocked
Actor Busfield indicted
UK police search 2 properties
Man charged over threat
Reach interim trade deal
Darron Lee charged
Defends $200B capex plan
NYPD sergeant convicted
Hall of Fame QB dies at 91
US sets June deadline
VA’s long‑awaited map plan
Plans Board of Peace meeting
CEO steps down
To open Greenland consulates
Drone attack in Sudan
Antetokounmpo joins Kalshi
Former MLB outfielder dies
RU hits UKR energy system
Judge tosses Missouri lawsuit
Will face state trial in June
Rep. Amodei to retire
Yasiel Puig found guilty
Resigns as Browns' DC
  • Privacy
  • Terms